BRAF and rectal cancer: MSI rectal cancer displays other distinctive features, with a significant mucinous component (84) and a decreased occurrence of MLH1 promoter hypermethylation and expression of BRAF mutations unlike Lynch dMMR colon cancer, which has no hMLH1promoter hypermethylation (85, 86).